Effect of pyrazinamide on nicotinamide adenine dinucleotide glycohydrolase of tuberculous host.
D000818:Animals; D004352:Drug Resistance, Microbial; D007538:Isoniazid / Q000494:pharmacology* / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000378:metabolism*; D009169:Mycobacterium tuberculosis; D009699:N-Glycosyl Hydrolases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009243:NAD; D009536:Niacinamide / Q000494:pharmacology* / Q000627:therapeutic use; D011718:Pyrazinamide / Q000494:pharmacology* / Q000627:therapeutic use
D009243:NAD; D009536:Niacinamide; D011718:Pyrazinamide; D009699:N-Glycosyl Hydrolases; D007538:Isoniazid